22157.jpg
Outlook on the Enteral Nutrition Global Market to 2030 - Trend Forecast and Growth Opportunities
January 07, 2022 04:08 ET | Research and Markets
Dublin, Jan. 07, 2022 (GLOBE NEWSWIRE) -- The "Global Enteral Nutrition Market 2020-2030 by Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Region: Trend Forecast...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Reports Inducement Grants For New Staff
January 06, 2022 16:05 ET | Recro Pharma, Inc.
SAN DIEGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
New logo with tagline.jpg
Vaxcyte Announces FDA Clearance of Investigational New Drug Application for VAX-24 for the Prevention of Invasive Pneumococcal Disease
January 06, 2022 08:30 ET | Vaxcyte, Inc.
-- Company Expects to Deliver Topline Immunogenicity Results from the Phase 1/2 Clinical Study by End of 2022 -- -- VAX-24 is a 24-Valent Pneumococcal Conjugate Vaccine Candidate Designed to Provide...
lumos.png
Lumos Pharma to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
January 05, 2022 09:00 ET | Lumos Pharma, Inc.
AUSTIN, Texas, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company...
Logo (3).png
Stevia Market Worth $1.11 Billion by 2028 - Exclusive Report by Meticulous Research®
January 04, 2022 09:00 ET | Meticulous Market Research Pvt. Ltd.
London, Jan. 04, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled “Stevia Market by Type (Extract [Powder, Liquid], Leaves); Nature (Conventional, Organic); Components (Reb...
Onconova Logo BLUE.jpg
Onconova Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
January 04, 2022 08:00 ET | Onconova Therapeutics, Inc.
NEWTOWN, Pa., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
22157.jpg
2021 Outlook on Pediatrics Partnering Deals - In-depth Review of Deals Entered into by the Top 25 Most Active Dealmakers
January 04, 2022 05:23 ET | Research and Markets
Dublin, Jan. 04, 2022 (GLOBE NEWSWIRE) -- The "Global Pediatrics Partnering 2010-2021: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering. Global...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro to Present at H.C. Wainwright BioConnect 2022 Conference
January 03, 2022 07:00 ET | Recro Pharma, Inc.
SAN DIEGO and GAINESVILLE, Ga., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex...
EBLarge.PNG
EnBiotix, Inc. Closes $11M Pre-Merger Financing
December 29, 2021 02:30 ET | EnBiotix, Inc.
BOSTON, Dec. 29, 2021 (GLOBE NEWSWIRE) -- EnBiotix, Inc., a rare disease company currently focused on chronic respiratory disorders, today announced the closing of an $11M pre-merger, convertible...
Rapid Micro Biosystems logo
Rapid Micro Biosystems Announces Appointment of Inese Lowenstein to Board of Directors
December 23, 2021 17:16 ET | Rapid Micro Biosystems, Inc.
LOWELL, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...